You have read all your free articles, to continue reading subscribe to read the rest of this content.
Moberg Pharma's head of US operations, Steve Cagle, will resign by the end of January 2015. Steve Cagle has been part of the management team at Moberg Pharma since November 2012. "I am proud of the achievements during the last two years. We have almost doubled the net sales in…
The Board of Directors of LEO Pharma and President and CEO Catherine Mazzacco have jointly agreed that she will resign from her current role and leave the company. LEO Pharma has recently completed the first phase of its strategic transformation process – including the development of a new capiAlready a…
Elicera Therapeutics has announced that Karin Hoogendoorn has been appointed to the Board. The company works for an accelerated development of Elicera’s next generation oncolytic virus and CAR T-cell clinical and pre-clinical programs, together with its iTANK platform for optimizing CAR T-cellsAlready a subscriber Login You have read all your…
Capitainer has announced that Mikael Ström (PhD) has been appointed as Business Development Manager. He joins the team, bringing valuable large scale hospital laboratory expertise, as Capitainer continues to add new applications for their proprietary qDBS dried blood sampling technology, states Already a subscriber Login You have read all your…
